Skip to main content
Main navigation
Home
About pCPA
Who We Are
Governance
FAQs
Negotiations
Recent Updates
Forms and Publications
Brand Name Drugs
Negotiations Status
Negotiation Process
Generic Drugs
Biologics/Biosimilars
Contact Us
EN
FR
Stivarga (regorafenib)
pCPA File Number:
21040
Negotiation Status:
Concluded with an LOI
Indication(s):
Unresectable Hepatocellular Carcinoma
Sponsor/Manufacturer:
Bayer Inc.
CADTH Project Number:
pCODR 10119
pCPA Engagement Letter Issued:
2018-09-10
Negotiation Process Concluded:
2019-03-07